RDD Blog » CRO

R&D Directions Insider

Archive for the ‘ CRO ’ Category

Fast-tracking proof of concept

Friday, September 17th, 2010

In this month's issue of R&D Directions, we talk about the need for contract research organizations to truly differentiate their services for a pharma client base that, given various circumstances, has become increasingly selective. For the clinical outsourcing provider, that means coming up with inventive and lasting solutions to help ...

Posted in CRO, Uncategorized, clinical trials | No Comments »

CROs juggle uncertainty, optimism

Tuesday, August 10th, 2010

The latest earnings season for the top publicly traded contract research organizations is over (Parexel released fiscal year 2010 results yesterday), leaving eyes now focused ahead at just what path clinical outsourcing will take the rest of the year and beyond. Many CROs are unsure whether continued market conditions will ...

Posted in CRO, clinical trials | 1 Comment »

Recruitment reigns at DIA

Friday, June 18th, 2010

Patient recruitment and retention was a major theme at this weekâ€™s 46th DIA Annual Meeting in Washington, both in the educational sessions and on the show floor. By my count, the conference featured at least 11 panels exploring the topic, ranging in focus from who should be accountable for patient ...

Posted in CRO, Uncategorized, clinical trials | 1 Comment »

Report: Fixing trial start-up woes requires new way of thinking

Friday, March 19th, 2010

Life sciences R&D is becoming an increasingly networked and externalized practice â€“ just see the latest merger, licensing deal, or joint venture for proof. Therefore, experts say, it is even more critical for drug companies to rethink the way they mange the various components of a clinical trial, where several ...

Posted in CRO, clinical trials | 1 Comment »

Charles River’s preclinical site suspension to cost 300 jobs

Monday, January 11th, 2010

Charles River Laboratories International Inc. has provided additional details regarding todayâ€™s announcement that the company is suspending operations at its Shrewsbury, Mass., preclinical facility in the middle of the year. According to the worldâ€™s third-ranked publicly traded CRO, 300 people will be laid off as a result of the move. ...

Posted in CRO | 1 Comment »

Emerging markets push has CRO at ready

Wednesday, December 2nd, 2009

A common theme echoed by big pharma these days, particularly during the recent blitz of third-quarter earnings releases, is a renewed focus on emerging markets. (Sanofi-Aventis and GlaxoSmithKline are two notable examples). Of course, the importance of tapping emerging markets â€“ both for drug research and commercial medicines â€“ has ...

Posted in CRO, Uncategorized, clinical trials | No Comments »

PPD puts skin in the game with Celtic alliance

Friday, October 30th, 2009

The typical CRO/sponsor relationship can be prone to delays as a result of the way trials are set up or misunderstandings between the parties. PPD is looking to avoid such delays by bringing products to market more quickly with its recent agreement to invest $100 million in Celtic Therapeutics Holdings ...

Posted in CRO | No Comments »

Big stage for diabetes hopeful

Friday, August 28th, 2009

Recent regulatory setbacks aside, Takeda Pharmaceutical Co. is plowing full steam ahead on its quest to win approval for the companyâ€™s key type 2 diabetes drug alogliptin, another potential entrant into the suddenly competitive field of DPP-4 inhibitors. The Japanese drug giant said today that it received the â€œall-clearâ€ from FDA ...

Posted in CRO, Uncategorized, clinical trials, diabetes, filed for approval | No Comments »

CROs bear brunt as well, numbers show

Wednesday, July 22nd, 2009

Earnings season is upon us once again and when it comes to the drug industry, itâ€™s not just the big fish in big pharma that are under the microscope these days. The top publicly traded contract research organizations are also dealing with added scrutiny as they try to withstand the ...

Posted in CRO, Uncategorized | No Comments »

Growing movement toward independent contracting

Monday, March 9th, 2009

During these tough economic times, when employment opportunities are scarce, more people are looking to other forms of income, such as independent contracting. According to a recent survey conducted by Redtree People Ltd., 60% of clinical research personnel have considered becoming contractors in the past and over 84% said they ...

Posted in CRO, recession | No Comments »

©2012 UBM Canon